Diabetes Mellitus, Type 2Diabetic RetinopathyEmergency Service, Hospital
Dr. Jared Mark Weed, MD
NPI1528596129PAC ID1355610791
- Medicare services, 2024
- 1,782
- Medicare patients, 2024
- 634
- Part D claims, 2024
- 1,195
- Publications
- 2
- MIPS score, 2024
- 92
- Practice address
- 5900 Corporate Dr, Pittsburgh, PA 15237-7005
- Practice phone
- Call (412) 367-2333
- Professional email
- Get professional email
- Personal email
- Get personal email
- Mobile number
- Get mobile number
Primary practice
North Park Ophthalmology
Eye care practice · Pittsburgh, Pennsylvania
Find Dr. Weed's professional email, personal email and mobile number
Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.
Dr. Jared Mark Weed is an ophthalmologist in Pittsburgh, Pennsylvania
Dr. Weed practices at North Park Ophthalmology in Pittsburgh, Pennsylvania.
Dr. Weed's NPI, 1528596129, was assigned on May 25, 2017. Dr. Weed graduated from University of Pittsburgh School of Medicine in 2017. Dr. Weed holds Pennsylvania license MD474005.
NPI and contact details
- NPI
- 1528596129NPI Registry (opens in a new tab)
- Medicare PAC ID
- 1355610791
- NPI enumeration date
- May 25, 2017
- NPI status
- Active
- Accepts Medicare assignment
- Yes
- Practice phone
- (412) 367-2333
- Professional email
- Get email
- Personal email
- Get email
- Mobile number
- Get number
- Sex
- Male
- Estimated age
- 35
- Medical school graduation
- 2017
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Affiliation Data; and Doctors and Clinicians National Downloadable File (CMS)
Dr. Jared Mark Weed practices at North Park Ophthalmology in Pittsburgh, Pennsylvania
Dr. Weed's primary practice is North Park Ophthalmology, at 5900 Corporate Dr, Pittsburgh, PA 15237-7005. The practice phone is (412) 367-2333.
- North Park Ophthalmology5900 Corporate Dr, Pittsburgh, PA 15237-7005Phone(412) 367-2333
Source: Dmand AI Affiliation Data
Dr. Jared Mark Weed is affiliated with 3 sites of care and 2 medical groups
Dr. Weed's primary practice is North Park Ophthalmology in Pittsburgh, Pennsylvania. Dr. Weed is also affiliated with WellSpan Good Samaritan Hospital. Dmand AI also links Dr. Weed to 2 more medical groups and 1 ambulatory surgery center, each named with a free account.
North Park OphthalmologyPrimary
Source: Dmand AI Affiliation Data
Dmand AI tracks the EHR system at Dr. Jared Mark Weed's practice
Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Weed practices, 3 sites in all. Vendor and product names are available with a free account.
| Site | EHR vendor and product |
|---|---|
| North Park Ophthalmology | Available with a free account |
| +2 more sites and 2 medical groups | Available with a free account |
Source: Dmand AI Technology Install Data
For health IT teams
See the EHR and IT leaders at every site where Dr. Weed practices
Dmand AI maps EHR vendors, IT decision makers and buying committees across each health system and 6.2K+ hospitals, with verified contacts in the same login.
Dr. Jared Mark Weed is one of 843 ophthalmologists in Pennsylvania
Ophthalmology is Dr. Weed's primary specialty in the NPI Registry, under taxonomy code 207W00000X. Dr. Weed is licensed in Pennsylvania.
Specialties and state licenses
- Ophthalmology, PennsylvaniaPrimary
Ophthalmologists near Dr. Weed
Counts of ophthalmologists with a Dmand AI profile, by place and practice. Each opens the list.
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks
Dr. Jared Mark Weed billed Medicare for 1,782 services in 2024
CMS data shows 1,782 Medicare services from Dr. Weed across 16 procedure codes in 2024, for 634 Medicare patients. Medicare paid $119,876 for them.
Medicare services, 20241,782
Medicare patients634
Paid by Medicare$119,876
Procedure codes16
Dr. Weed's Medicare services by type, 2023 to 2024
- 2023
- 2024
- Tests and treatments
- 2023: 7712024: 1,35476%
- Office and hospital visits
- 2023: 1762024: 32082%
- Surgery
- 2023: 322024: 91184%
- Imaging
- 2023: 152024: 1713%
Where Dr. Weed's Medicare services took place, 2024
- In an office1,69195%
- In a facility915%
Dr. Weed compared with the Pennsylvania median for ophthalmologists, 2024
- Dr. Weed
- Pennsylvania median
- Medicare services
- 1,782vs 1,33633% above
- Medicare patients
- 634vs 52421% above
- Part D claims
- 1,099vs 62077% above
Medians across 854 ophthalmologists in Pennsylvania with Dmand AI profiles that report each measure.
Dr. Weed's most billed Medicare procedure codes, 2024
CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.
Need commercial claims for Dr. Weed?
Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Weed and other ophthalmologists in Pennsylvania.
Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks
Dr. Jared Mark Weed treated 634 Medicare patients in 2024, average age 77
CMS counts 634 Medicare patients who saw Dr. Weed in 2024. The largest group is 65 to 74, with 257 patients. 75% of them have high cholesterol, and 74% have high blood pressure. 3% are also on Medicaid. Their average risk score is 1.05, where 1.00 is the Medicare average.
Across all payers, Dmand AI patient panel data puts Dr. Weed's median patient age at 77, with 59% women.
Medicare patients, 2024634
Average age77
Average risk score1.05
Also on Medicaid3%
Dr. Weed's Medicare patients by age, 2024
Dr. Weed's Medicare patients by sex, 2024
- Women41065%
- Men22435%
Chronic conditions among Dr. Weed's Medicare patients, 2024
- High cholesterol75%
- High blood pressure74%
- Arthritis49%
- Diabetes26%
- Chronic kidney disease22%
- Ischemic heart disease22%
- Anxiety21%
- Osteoporosis21%
Share of Medicare patients with each condition. A patient can have several.
Dr. Weed's patients across all payers
Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.
Patient panel by age, all payers
Median age 77
Patient panel by sex, all payers
- Women59%
- Men41%
Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data
Dr. Jared Mark Weed wrote 1,195 Medicare Part D claims in 2024
In 2024, Dr. Weed wrote 1,195 Medicare Part D claims for 361 patients. 74% of them were for generic drugs. CMS names the drug for 1,099 of them, across 16 drugs with 11 or more claims each, at $103,669 in total drug cost. In 2023, CMS named 1,108 claims across 18 drugs.
Part D claims, 20241,195
Drugs named by CMS16
Total drug cost$103,669
Part D patients361
Dr. Weed's Part D claims by kind of drug, 2024
- Generic888 claims74%
- Brand-name307 claims26%
Dr. Weed's most prescribed drugs by claims, 2024
CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.
Drug classes CMS tracks in Dr. Weed's Part D claims, 2024
- Antibiotics1%16 of 1,195 claims
Share of all Part D claims for each drug class CMS reports on. Classes with no claims are left out.
Part D claims for drugs CMS names, 2023 to 2024
- 2023
- 2024
- Claims for drugs CMS names
- 2023: 1,1082024: 1,0991%
Drugs named by CMS: 16 in 2024, 18 in 2023.
Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data
Dr. Jared Mark Weed scored 92 out of 100 in Medicare's MIPS program for 2024
CMS publishes a Merit-based Incentive Payment System (MIPS) score of 92 out of 100 for Dr. Weed for performance year 2024, reported as part of a group. Dr. Weed accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 257 procedures of cataract surgery by Dr. Weed, more than 87% of the clinicians it reports for that procedure.
- Accepts Medicare assignment
- Yes
Dr. Weed's MIPS scores, performance year 2024
- 92of 100Final score
- 100of 100Quality
- 40of 100Improvement Activities
- 72of 100Cost
Each score is out of 100. The final score weighs the categories CMS scored for this clinician.
Where Dr. Weed ranks in Medicare procedure volume
- Cataract surgery
- 87th percentile257 procedures
CMS ranks each clinician against every clinician it reports for the same procedure category.
Sources: Doctors and Clinicians National Downloadable File (CMS); Clinician Public Reporting: Overall MIPS Performance (CMS), 2024 data, released September 10, 2026; and Doctors and Clinicians Utilization Data (CMS)
For MedTech and pharma teams
Find ophthalmologists like Dr. Weed by procedure volume and prescribing
Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.
Dr. Jared Mark Weed has 2 publications on record
Dmand AI links 2 papers to Dr. Weed in 2022. Dr. Weed's most frequent co-authors are Antonio Meola, MD, Evan L. Waxman and Andrew Mitchell Williams, MD.
Papers2
Dr. Weed's most frequent co-authors
- Antonio Meola, MD1 shared paper
- Evan L. Waxman1 shared paper
- Andrew Mitchell Williams, MD1 shared paper
Recent publications by Dr. Weed
Atlases as TopicBrain StemConnectome
See who Dr. Weed researches with
Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Weed works with, so you can find a warm path to the right ophthalmologists.
Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage
Dr. Jared Mark Weed received $979 in industry payments from 2018 to 2025
CMS Open Payments shows 32 general payments to Dr. Weed from 11 drug and device companies from 2018 to 2025. Food and beverage make up the largest share, 90% of the total. Alcon Laboratories Inc paid the most, $393.
General payments to Dr. Weed by program year, 2018 to 2025
General payments to Dr. Weed by kind, 2018 to 2025
$979in total
- Food and beverage$87990%
- Education$10010%
Companies that paid Dr. Weed the most, 2018 to 2025
Share is of all general payments to this clinician.
Source: Open Payments (CMS), 2025 data, released July 7, 2026
Dr. Jared Mark Weed graduated from University of Pittsburgh School of Medicine
Dr. Weed graduated from University of Pittsburgh School of Medicine in 2017.
- Medical school
Source: Dmand AI Professional Profile Data
Sources for Dr. Jared Mark Weed's profile data
| Data on this page | Source |
|---|---|
| NPI, name, sex, specialty and licenses | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data |
| Practice locations and phone | Dmand AI Affiliation Data |
| Primary practice, affiliations and health system | Dmand AI Affiliation Data |
| Medicare services and procedure codes | Medicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab) |
| State medians for the same specialty | Dmand AI Peer Benchmarks |
| Medicare patients and the all-payer patient panel | Dmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab) |
| Part D prescribing | Medicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab) |
| MIPS scores, telehealth, assignment and procedure percentiles | Doctors and Clinicians National Downloadable File (CMS) (opens in a new tab)Clinician Public Reporting: Overall MIPS Performance (CMS) (opens in a new tab)Doctors and Clinicians Utilization Data (CMS) (opens in a new tab) |
| Publications, topics and co-authors | PubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage |
| Industry payments | Open Payments (CMS) (opens in a new tab) |
| Training, board certification and memberships | Dmand AI Professional Profile Data |
| EHR at each practice site | Dmand AI Technology Install Data |
| Similar physicians | Dmand AI Affiliation Data |
Data last refreshed October 2026Report an inaccuracyRemove my information
FAQ
Frequently asked questions about Dr. Jared Mark Weed
Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.
What is Dr. Jared Mark Weed's NPI number?
Dr. Jared Mark Weed's NPI number is 1528596129. It was assigned on May 25, 2017, and it is active in the NPI Registry.
What kind of doctor is Dr. Jared Mark Weed?
Dr. Jared Mark Weed is an ophthalmologist in Pittsburgh, Pennsylvania. The primary specialty in the NPI Registry is Ophthalmology Physician (taxonomy code 207W00000X).
Where does Dr. Jared Mark Weed practice?
Dr. Weed practices at 5900 Corporate Dr, Pittsburgh, PA 15237-7005. Dr. Weed's primary practice is North Park Ophthalmology in Pittsburgh, Pennsylvania. Dmand AI also links Dr. Weed to 2 medical groups and 1 ambulatory surgery center.
What is Dr. Jared Mark Weed's office phone number?
The practice phone on file for Dr. Weed is (412) 367-2333.
What is Dr. Jared Mark Weed's medical license number?
Dr. Weed holds Pennsylvania license MD474005.
Which hospitals is Dr. Jared Mark Weed affiliated with?
Dr. Weed is affiliated with WellSpan Good Samaritan Hospital.
Does Dr. Jared Mark Weed accept Medicare?
Yes. CMS data shows Dr. Weed billed Medicare for 1,782 services in 2024, and Dr. Weed accepts Medicare assignment.
What is Dr. Jared Mark Weed's MIPS score?
Dr. Weed's MIPS final score for performance year 2024 is 92 out of 100, reported as part of a group.
How many Medicare patients does Dr. Jared Mark Weed see?
CMS counts 634 Medicare patients who saw Dr. Weed in 2024, with an average age of 77.
What services does Dr. Jared Mark Weed bill to Medicare?
In 2024, Dr. Weed's most billed Medicare services were eye exam or test (92014), eye exam or test (92250) and eye exam or test (92083).
Show 6 more questionsShow fewer questions
Where did Dr. Jared Mark Weed go to medical school?
Dr. Weed graduated from University of Pittsburgh School of Medicine in 2017.
What drugs does Dr. Jared Mark Weed prescribe most?
In 2024 Medicare Part D data, Dr. Weed's most prescribed drugs by claims were Latanoprost, Timolol Maleate and Prednisolone Acetate.
Has Dr. Jared Mark Weed received payments from drug or device companies?
CMS Open Payments shows $979 in general payments to Dr. Weed from 11 companies from 2018 to 2025. The largest total came from Alcon Laboratories Inc.
How long has Dr. Jared Mark Weed been practicing?
Dr. Weed graduated from medical school in 2017, 9 years ago.
Does Dr. Jared Mark Weed do research?
Dmand AI links 2 publications to Dr. Weed.
Who does Dr. Jared Mark Weed publish with?
Dr. Weed's most frequent co-authors are Antonio Meola, MD (1 shared paper), Evan L. Waxman (1 shared paper) and Andrew Mitchell Williams, MD (1 shared paper).
Selling to ophthalmology practices?
See ophthalmologists in Pennsylvania by site of care and group
Find the practices, groups and hospitals they work with, and the right people to contact at each.
- 30 days free
- Self-serve
- No credit card